March 15 - 17, 2014 | Qatar
Featuring: Huda Akil (University of Michigan), Karl Deisseroth (Stanford University)
Join global experts in clinical neuroscience in Doha, Qatar, for a 2.5 day, two-track conference that will feature recent advances in the understanding and treatment of mood disorders, stroke, and traumatic brain injury.
Monday, March 24, 2014 | 8:00 AM - 5:00 PM
Speakers: David Alland (Rutgers New Jersey Medical School), Stephanie Boisson-Dupuis (The Rockefeller University), Andrea M. Cooper (Trudeau Institute), Jerrold J. Ellner (Boston Medical Center), Daniel E. Everitt (TB Alliance), Michael S. Glickman (Memorial Sloan-Kettering Cancer Center), Kathleen A. McDonough (Wadsworth Center ), Steven A. Porcelli (Albert Einstein College of Medicine), Kyu Rhee (Weill Cornell Medical College), G. Marcela Rodriguez (Rutgers New Jersey Medical School), Padmini Salgame (Rutgers New Jersey Medical School), Marie Samanovic (NYU Langone Medical Center), Jessica C. Seeliger (Stony Brook University)
TB is a curable infection that should be a disease of the past, yet a third of the world's population remains affected. Join us on World TB Day to explore scientific insights towards novel diagnostics, therapeutics and vaccine-related tools.
Tuesday, March 25, 2014 | 12:00 PM - 4:00 PM
Speakers: Rolf Brekken (UT Southwestern), Jessica S. Donington (NYU Langone Medical Center), Balazs Halmos (Columbia University Medical Center), Roy S. Herbst (Yale School of Medicine), Suresh S. Ramalingam (Emory University)
Recent treatment advances may improve lung cancer patient survival rates, as understanding genetic heterogeneity can improve trial patient selection. Hear updates on common mutations, intraoperative chemotherapy, and insights from clinical trials.
Tuesday, April 8, 2014 | 8:30 AM - 4:30 PM
Speakers: Dan V. Iosifescu (Icahn School of Medicine at Mount Sinai), Daniel C. Javitt (Columbia University and Nathan Kline Institute), John H. Krystal (Yale University), Andrew F. Leuchter (University of California, Los Angeles), Gregory Light (University of California, San Diego), Siva Digavalli (Bristol-Myers Squibb), Eva Redei (Northwestern University), Steven J. Siegel (University of Pennsylvania)
Recent breakthrough insights from clinical studies are illuminating the neurobiology of psychiatric disorders. This symposium explores differences in sensory processing, imaging, and other biomarkers that may translate findings to animal models.
Thursday, April 10, 2014 | 8:30 AM - 4:30 PM
Speakers: Robert Balaban (National Heart, Lung, and Blood Institute, NIH), Robert Bao (Massachusetts General Hospital), Salvatore DiMauro (Columbia University Medical Center), Steven Gross (Weill Cornell Medical College), Costas A. Lyssiotis (Weill Cornell Medical College), Vamsi K. Mootha (Harvard Medical School), Jared Rutter (University of Utah School of Medicine), Hazel H. Szeto (Weill Cornell Medical College), Benjamin P. Tu (UT Southwestern Medical Center)
Damage to mitochondria, which are critical in metabolism, underlies a wide range of human diseases, making them an important therapeutic target. Researchers aim to characterize and cure diseases arising from aberrant mitochondrial metabolism.
Tuesday, February 18, 2014 | 8:30 AM - 4:30 PM
Speakers: John DiPersio (Washington University School of Medicine), William R. Drobyski (Medical College of Wisconsin), James Ferrara (University of Michigan), David L. Porter, MD, University of Pennsylvania Medical Center, Robert J. Soiffer (Dana-Farber Cancer Institute), Megan Sykes (Columbia University), Marcel RM van den Brink (Memorial Sloan Kettering Cancer Center)
Mechanisms that cause graft-versus-host disease (GvHD), a major cause of mortality after stem cell transplants, must be inhibited while preserving the graft-versus-tumor (GvT) response. Explore recent advances in separating GvHD from GvT effects.
Wednesday, February 5, 2014 | 7:00 PM - 8:30 PM
Featuring: Allan Kellehear, Jeffrey J. Kripal, and Lani Leary
Moderator: Steve Paulson
How do we cope with the inevitability of our mortality? Experts in psychology, philosophy and sociology come together to share a multicultural perspective on death, dying, and what lies beyond.
Tuesday, January 28, 2014 | 8:30 AM - 4:30 PM
Speakers: Nahor Haddish-Berhane (Pfizer), Sara Hurvitz (UCLA Medical Center), Omar Kabbarah (Genentech Inc.), Peter D. Senter (Seattle Genetics, Inc.), Dhaval K. Shah (The State University of New York at Buffalo), Stacey S. Shord (Food and Drug Administration), Melissa M. Schutten (Genentech Inc.), and Puja Sapra (Pfizer), Alan Wahl (Ambrx)
Antibody-drug conjugates (ADCs) promise safer, more effective therapies than standard anti-cancer drugs. This symposium highlights linker-payload and coupling chemistries, ADC development, biomarker and patient selection, and regulatory perspectives.
Wednesday, December 11, 2013 | 7:00 PM - 8:30 PM
Featuring: Peter Fenwick, Kevin Nelson, Mary Neal, Sam Parnia
Moderator: Steve Paulson
What happens when we die? Recent medical advances have led to increased reports of "out of body" or "near death" experiences. Can these experiences be explained, and what can we learn from the transformative accounts of those who have nearly died?
Organizers: Mandë Holford (Hunter College, CUNY; American Museum of Natural History), Steven Gross (Weill Cornell Medical College), and Jennifer Henry (The New York Academy of Sciences)
Keynote Speaker: Baldomero M. Olivera (University of Utah)
Venomous animals, including spiders, snakes, scorpions, sea snails, leeches, and others, produce millions of bioactive compounds, offering enormous potential for venom-based drug discovery.
Organizers: John E. Hambor (Boehringer-Ingelheim Pharmaceuticals) and Jennifer Henry (The New York Academy of Sciences)
Dendritic cells offer promise in the development of cancer vaccines.
Organizers: Katalin Kauser (Bayer HealthCare), Scott MacDonnell (Boehringer-Ingelheim Pharmaceuticals), Silvia Pomposiello (F. Hoffmann-La Roche), Carolyn Foster, and Jennifer Henry (The New York Academy of Sciences)
Fibrosis is common in chronic organ injury, leading to progressive life-threatening outcomes. This eBriefing reviews the link between fibrosis and disease and explores how to use biomarkers and imaging to translate laboratory results into clinical success.
Moderator: Ko-Yung Tung (Morrison & Foerster LLP)
Featuring: Kiyoshi Kurokawa (GHIT Fund), Peter Piot (London School of Hygiene & Tropical Medicine, UK), B.T. Slingsby (GHIT Fund), Mel Spigelman (Global Alliance for TB Drug Development), and Ann M. Veneman (formerly of UNICEF)
Experts discussed recent successes and setbacks in global health.
Foods high in antioxidants are believed to fight oxidative stress. But what is oxidative stress? Two scientists from a recent NYAS conference break it down and discuss whether antioxidants have superpowers.
Delve into the world of prebiotic and probiotic science. We talk to three people in the field and learn why keeping the good microbes in our bodies happy means a lot for health.
Neuropsychologist Jeffrey Halperin is using behavioral therapy on preschoolers with attention deficit hyperactivity disorder (ADHD). He hopes to train their brains to develop in new ways and if effective, his therapies could offer permanent, drug-free treatment for the disorder.
Researchers at Harvard have discovered why the headaches of some migraine sufferers worsen when the person is exposed to light. Rami Burstein, the study's senior author, explains what's happening in the brain, and how they made the breakthrough.
Translational Medicine Initiative
The Translational Medicine Initiative represents a three-year partnership between the New York Academy of Sciences and the Josiah Macy, Jr. Foundation to support the translation of basic science research into clinical applications.
Learn more at www.nyas.org/TransMed.